Antiepileptic drug treatment patterns and economic burden of commercially-insured patients with refractory epilepsy with partial onset seizures in the United States.

Journal of medical economics

Volumn 16, Issue 2, 2013, Pages 240-248

  Chen, Shih Yin ^a   Wu, Ning ^b   Boulanger, Luke ^b   Sacco, Patricia ^b  

^a UNITED BIOSOURCE CORPORATION   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL PRACTICE; COST OF ILLNESS; DRUG COMBINATION; ECONOMICS; FEMALE; FOCAL EPILEPSY; HEALTH CARE COST; HEALTH INSURANCE; HUMAN; INFANT; INSURANCE; MALE; MIDDLE AGED; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SEIZURE; UNITED STATES;

ADOLESCENT; ADULT; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; COST OF ILLNESS; DRUG THERAPY, COMBINATION; EPILEPSIES, PARTIAL; FEMALE; HEALTH EXPENDITURES; HUMANS; INFANT; INSURANCE CLAIM REVIEW; INSURANCE, HEALTH; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; RETROSPECTIVE STUDIES; SEIZURES; UNITED STATES; YOUNG ADULT;

EID: 84879016571     PISSN: None     EISSN: 1941837X     Source Type: None    
DOI: 10.3111/13696998.2012.751918     Document Type: Article

References (0)